Related Experiment Video
Updated: May 20, 2025

Author Spotlight: Time and Cost-Effective Fibrinogen-PAGE for Fibrinogenolytic Studies
Published on: April 19, 2024
Inhibitory mechanism study of soyasaponins on thrombin: extraction, purification, and functional property analysis
Mengqian Chen1, Pengcheng Wang1, You Li1
1China Food Flavor and Nutrition Health Innovation Center, Beijing Technology and Business University; National Soybean Processing Industry Technology Innovation Center, Beijing Technology and Business University, Beijing 100048, China. liyou@btbu.edu.cn.
Abstract:
This study aimed to investigate the inhibitory effects of soyasaponins extracted from soybean meal on thrombin, thereby providing scientific evidence for the application of soybean meal byproducts in functional foods and cardiovascular disease prevention. Using a combination of resin column chromatography and preparative liquid chromatography, six extracts were isolated and purified. Among these, four extracts (SE3, SE4, SE5, SE6) exhibited significant thrombin inhibitory activity. Enzyme activity assays revealed that SE6 showed the strongest inhibitory effect, with an IC50 of 1.36 mg mL-1. Component analysis indicated that SE3 contained a soyasaponins content as high as 91.2%, while SE4, SE5, and SE6 were mixtures of soyasaponins and isoflavones. Molecular docking analysis demonstrated that soyasaponins, such as Soyasapogenol E, had the highest binding affinity to thrombin. Moreover, the interactions of SE3, SE4, SE5, and SE6 with thrombin induced structural changes, reducing or eliminating the α-helical structures. These interactions were accompanied by fluorescence quenching effects, further elucidating the inhibition mechanism. The findings confirm that soyasaponins exhibit thrombin inhibitory activity. Additionally, a novel hypothesis was proposed, suggesting a potential synergistic effect between saponins and isoflavones. This synergy highlights the potential of soyasaponins and their complexes in the development of functional foods for cardiovascular health.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Intracellular Signaling Affects Focal Adhesions
Some...

